Opaleye Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,000,000
Closed -$12.4M 53
2016
Q4
$12.4M Sell
1,000,000
-45,000
-4% -$542K 7.33% 3
2016
Q3
$14.3M Sell
1,045,000
-205,000
-16% -$2.06M 7.49% 3
2016
Q2
$9.24M Hold
1,250,000
6.17% 3
2016
Q1
$7.99M Sell
1,250,000
-60,000
-5% -$336K 4.98% 2
2015
Q4
$8.19M Hold
1,310,000
3.42% 9
2015
Q3
$7.65M Sell
1,310,000
-190,000
-13% -$1.46M 3.76% 8
2015
Q2
$12.4M Hold
1,500,000
4.94% 5
2015
Q1
$12.4M Sell
1,500,000
-25,000
-2% -$185K 5.74% 3
2014
Q4
$10.5M Buy
1,525,000
+25,000
+2% +$156K 5.29% 5
2014
Q3
$8.1M Sell
1,500,000
-160,000
-10% -$934K 6.31% 4
2014
Q2
$10.6M Sell
1,660,000
-10,000
-0.6% -$68.8K 9.12% 3
2014
Q1
$13.5M Hold
1,670,000
9.94% 2
2013
Q4
$11.9M Buy
+1,670,000
New +$9.02M 9.31% 4

Other funds holding ARIA

Opaleye Management's ARIA Position: Q1 2017 in Review

Opaleye Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,000,000 shares — an estimated $12.4M sold.

Opaleye Management first reported a position in ARIA in Q4 2013 and held it in 13 quarters. The position peaked at $14.3M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Opaleye Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Opaleye Management sold 1,000,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $12.4M.
  • Opaleye Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 13 quarters.
  • Opaleye Management's Ariad Pharmaceuticals Inc position peaked at $14.3M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Opaleye Management's 13F filing for Q1 2017, filed 15 May 2017.